Jerusalem Pharmaceuticals Co. Ltd. (PEX:JPH)

Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
4.000
0.00 (0.00%)
At close: Oct 8, 2025
Market Cap51.01M
Revenue (ttm)31.34M
Net Income (ttm)5.48M
Shares Out18.00M
EPS (ttm)0.30
PE Ratio9.31
Forward PEn/a
Dividend0.06 (2.00%)
Ex-Dividend DateApr 30, 2025
Volume500
Average Volume788
Open4.000
Previous Close4.000
Day's Range4.000 - 4.000
52-Week Range3.490 - 4.200
Beta0.07
RSI46.70
Earnings DateNov 10, 2025

About Jerusalem Pharmaceuticals

Jerusalem Pharmaceuticals Co. Ltd. develops, manufactures, and markets pharmaceutical products in Palestine, the Middle East, North Africa, and internationally. It offers range of over-the-counter, prescription pharmaceutical, and nutritional supplements products. The company produces approximately 300 pharmaceutical products in various dosage forms, such as tablets, capsules, sterile injectables, suspensions, syrups, powders, suppositories, ovules, creams, ointments, and ear and nose drops, as well as solutions. It also produces detergent, cos... [Read more]

Industry Pharmaceutical Preparations
Founded 1969
Employees 531
Stock Exchange Palestine Stock Exchange
Ticker Symbol JPH
Full Company Profile

Financial Performance

In 2024, Jerusalem Pharmaceuticals's revenue was $39.82 million, an increase of 0.42% compared to the previous year's $39.65 million. Earnings were $5.04 million, a decrease of -27.58%.

Financial numbers in USD Financial Statements

News

There is no news available yet.